Rejuva Med Evaluation Study

CACI Rejuva Med is supported by clinical evaluation studies

CACI Rejuva Med is supported by clinical evaluation studies designed to assess both immediate and long-term treatment outcomes across a structured treatment programme. Conducted on participants aged 35 to 70, the study followed a full course of treatments using all five modalities within the Rejuva Med system, with one session per week over a six to eight-week period.

Skin was analysed using advanced imaging technology, including professional skin analysis systems, with assessments carried out before treatment, after each session, and two weeks following the final treatment. This allowed for accurate tracking of progressive improvements and overall skin health.

The results demonstrated visible improvements from the very first treatment, with more significant changes observed from mid-course onwards. Participants experienced enhanced skin texture, increased hydration, improved firmness, and a more radiant, even complexion. Reductions in redness and the appearance of fine lines and wrinkles were also noted. Importantly, results continued to improve with each treatment, highlighting the effectiveness of a consistent, course-based approach. Participant feedback further reinforced these findings, with high levels of satisfaction and visible, measurable results reported throughout the study.

These clinical findings position CACI Rejuva Med as a results-driven, non-invasive solution for advanced skin rejuvenation, delivering both instant impact and cumulative long-term benefits.

100% PARTICIPANT SATISFACTION
100% of participants noticed an immediate visible difference after their first treatment
100% of participants reported smoother, more hydrated skin
100% of participants saw progressive improvements after each treatment
100% of participants saw visible improvements by the end of a 6-8 treatment course
100% of participants would recommend Rejuva Med